These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 15611015)

  • 21. Novel Strategies to Address the Challenges in Top-Down Proteomics.
    Melby JA; Roberts DS; Larson EJ; Brown KA; Bayne EF; Jin S; Ge Y
    J Am Soc Mass Spectrom; 2021 Jun; 32(6):1278-1294. PubMed ID: 33983025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methodologies to decipher the cell secretome.
    Mukherjee P; Mani S
    Biochim Biophys Acta; 2013 Nov; 1834(11):2226-32. PubMed ID: 23376189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The ProteoMiner and the FortyNiners: searching for gold nuggets in the proteomic arena.
    Righetti PG; Boschetti E
    Mass Spectrom Rev; 2008; 27(6):596-608. PubMed ID: 18481254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stable isotope-coded proteomic mass spectrometry.
    Goshe MB; Smith RD
    Curr Opin Biotechnol; 2003 Feb; 14(1):101-9. PubMed ID: 12566009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Affinity proteomics: the role of specific binding reagents in human proteome analysis.
    Stoevesandt O; Taussig MJ
    Expert Rev Proteomics; 2012 Aug; 9(4):401-14. PubMed ID: 22967077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multidimensional protein identification technology: current status and future prospects.
    Kislinger T; Emili A
    Expert Rev Proteomics; 2005 Jan; 2(1):27-39. PubMed ID: 15966850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methods of comparative proteomic profiling for disease diagnostics.
    Steel LF; Haab BB; Hanash SM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 815(1-2):275-84. PubMed ID: 15652816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design of high-density antibody microarrays for disease proteomics: key technological issues.
    Borrebaeck CA; Wingren C
    J Proteomics; 2009 Aug; 72(6):928-35. PubMed ID: 19457338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cysteine tagging for MS-based proteomics.
    Giron P; Dayon L; Sanchez JC
    Mass Spectrom Rev; 2011; 30(3):366-95. PubMed ID: 21500242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analytical platforms for activity-based protein profiling--exploiting the versatility of chemistry for functional proteomics.
    Sieber SA; Cravatt BF
    Chem Commun (Camb); 2006 Jun; (22):2311-9. PubMed ID: 16733565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances in quantitative proteomics via stable isotope tagging and mass spectrometry.
    Tao WA; Aebersold R
    Curr Opin Biotechnol; 2003 Feb; 14(1):110-8. PubMed ID: 12566010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteomics: evolution of the technology.
    Patterson SD
    Biotechniques; 2003 Sep; 35(3):440-4. PubMed ID: 14513544
    [No Abstract]   [Full Text] [Related]  

  • 33. Recent advances in clinical proteomics using mass spectrometry.
    Dowling P; Meleady P; Henry M; Clynes M
    Bioanalysis; 2010 Sep; 2(9):1609-15. PubMed ID: 21083289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative analysis of different label-free mass spectrometry based protein abundance estimates and their correlation with RNA-Seq gene expression data.
    Ning K; Fermin D; Nesvizhskii AI
    J Proteome Res; 2012 Apr; 11(4):2261-71. PubMed ID: 22329341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.
    Smith JG; Gerszten RE
    Circulation; 2017 Apr; 135(17):1651-1664. PubMed ID: 28438806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protein arrays and their role in proteomics.
    Cahill DJ; Nordhoff E
    Adv Biochem Eng Biotechnol; 2003; 83():177-87. PubMed ID: 12934930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High throughput and accurate serum proteome profiling by integrated sample preparation technology and single-run data independent mass spectrometry analysis.
    Lin L; Zheng J; Yu Q; Chen W; Xing J; Chen C; Tian R
    J Proteomics; 2018 Mar; 174():9-16. PubMed ID: 29278786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteomics in heart failure: top-down or bottom-up?
    Gregorich ZR; Chang YH; Ge Y
    Pflugers Arch; 2014 Jun; 466(6):1199-209. PubMed ID: 24619480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biomarker discovery: proteome fractionation and separation in biological samples.
    Matt P; Fu Z; Fu Q; Van Eyk JE
    Physiol Genomics; 2008 Mar; 33(1):12-7. PubMed ID: 18162500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Obtaining Complete Human Proteomes.
    Martinez-Val A; Guzmán UH; Olsen JV
    Annu Rev Genomics Hum Genet; 2022 Aug; 23():99-121. PubMed ID: 35440146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.